Brain Health in Midlife
該当なし
完了
NCT06640842
| 対象疾患 | Brain Health, Gestational Hypertension, Alzheimer Disease, Dementia |
|---|
| 相 | 該当なし |
|---|
| スポンサー | University of Kansas Medical Center |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 24 名 |
|---|
| 介入(薬剤) | A combination of various tests and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy on brain health in midlife. |
|---|
| 開始日 | 2024年9月23日 |
|---|
| 完了日 | 2025年6月13日 |
|---|
| 結果公開日 | 2026年7月14日 |
|---|
概要
The purpose of this study is to learn if hypertensive disorders during pregnancy affects brain health in midlife.
Cardiometabolic Biomarkers - Glucose & Lipids
Baseline · mg/dL
| Hypertensive Disorder of Pregnancy | 93.25 ± 15.71 mg/dL |
|---|
| Healthy Pregnancy | 94.50 ± 13.53 mg/dL |
|---|
| Hypertensive Disorder of Pregnancy | 170 ± 38.69 mg/dL |
|---|
| Healthy Pregnancy | 172.50 ± 28.27 mg/dL |
|---|
| Hypertensive Disorder of Pregnancy | 92.58 ± 32.81 mg/dL |
|---|
| Healthy Pregnancy | 132.42 ± 83.07 mg/dL |
|---|
Cardiometabolic Biomarkers - Insulin
Baseline · uIU/mL
| Hypertensive Disorder of Pregnancy | 7.44 ± 3.63 uIU/mL |
|---|
| Healthy Pregnancy | 14.13 ± 12.97 uIU/mL |
|---|
Cardiometabolic Biomarkers - Hemoglobin A1C
Baseline · percentage of glycated hemoglobin
| Hypertensive Disorder of Pregnancy | 5.72 ± 1.09 percentage of glycated hemoglobin |
|---|
| Healthy Pregnancy | 5.45 ± 0.34 percentage of glycated hemoglobin |
|---|
BENITIONS で見る
ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。